Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients
SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the first prescription for VELSIPITY® has been written at Foshan Fosun Chancheng Hospital in Guangdong, under the "Hong Kong and Macau Medicine and Equipment Connect" policy, which...
Ubie Growth in 2024 Driven by Industry Leading Recognition, Collaborations with Patient Advocacy Groups and an Expanded Reach of More Than 4 Million Users
Strategic investment from Google and acceptance into Mayo Clinic Platform Accelerate program show an increasing understanding of Ubie's value to patients and healthcare Key platform innovations have led to increased user engagement, with a 30% increase in call to action engagement Results from two new analyses support Ubie's AI Symptom Checker's...
Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program
FRAMINGHAM, Mass., Dec. 17, 2024 /PRNewswire/ -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing Service Provider Program. Complete Genomics' Service Provider Program connects its customers to a network of service providers, offering access to...
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Agreement to Deliver Critical Medicines ITASCA, Ill., Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the "Agreement") with Sinopharm Holding Hubei New Special Medicine Co., Ltd. ("Sinopharm...
Origin Agritech Holds Successful 2025 R&D and Business Management Conference
BEIJING, Dec. 17, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, recently held its 2025 R&D and Business Management Conference in Beijing. The event brought together industry experts, including professors from China Agricultural University, the Beijing Academy of Agriculture and Forestry Sciences, and the Company's leadership team. The conference...
Xinhua Silk Road: Why is Pien Tze Huang selected as one of China’s brands favored by foreigners in 2024
BEIJING, Dec. 17, 2024 /PRNewswire/ -- Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang), a time-honored Chinese enterprise mainly engaging in pharmaceutical manufacturing, was selected as one of China's brands favored by foreigners in 2024 at the 2024 China Brand Day gala held in Shanghai in May this year. Why was Pien Tze Huang chosen? Pien Tze...
DPC Dash – Domino’s Pizza China Wins Seven-Star Award for Outstanding Contributions in Food Safety & Public Health for the Fourth Year
HONG KONG, Dec. 17, 2024 /PRNewswire/ -- DPC Dash – Domino's Pizza China ("DPC Dash" or the "Company") (1405.HK), the exclusive master franchisee for Domino's Pizza in the China Mainland, the Hong Kong Special Administrative Region of China, and the Macau Special Administrative Region of China, received recognition from the prestigious 2024...
Fangzhou Inc. Recognized as an “Outstanding Enterprise in Digital Intelligence” by Analysys Star
HANGZHOU, China, Dec. 17, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was recognized as an "Outstanding Enterprise in Digital Intelligence" on the "Analysys Star 2024 Annual Award List" (released December 10th), alongside prominent Internet players such as Alibaba and ByteDance. Fangzhou was selected for...
Great Bay Bio Completes First Close of Series B Financing
HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B financing round. This milestone was achieved with the round led by a syndication of a well-known strategic investment institution and its affiliate, Tiger Jade Pebble Accelerator. The financing also attracted participation from new investors, including a Hong...
GSK Leads Global Forum in Bangkok to Address Respiratory Health Challenges
GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok, Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to address pressing global challenges in respiratory diseases, focusing on innovative solutions and collaborative strategies to advance respiratory health worldwide. BANGKOK, Dec. 17, 2024 /PRNewswire/ -- Dr. Gur Levy, Respiratory Medical Expert...
